Integer grows sales 12% in Q2, driven by recent acquisitions

Integer (NYSE:ITGR) posted second-quarter results today that beat the overall consensus forecast on Wall Street.

The Plano, Texas-based medical device outsource manufacturer reported profits of $20.8 million, or 62¢ per share, on sales of $350 million for the three months ended July 1, for a bottom-line loss of 29.2% on sales growth of 12.2% compared with Q2 2021.

Adjusted to exclude one-time items, earnings per share were $1.04, 8¢ ahead of The Street, where analysts were looking for sales of $43.57 million.

“Integer delivered second quarter 2022 financial results consistent with our expectations, as sales grew 13% versus the first quarter 2022 and 12% versus prior year. Integer’s associates around the globe remain focused on delivering products for our customers and the patients they serve, while managing the challenges of the ongoing labor and supply chain dynamics,” President and CEO Joseph Dziedzic said in a news release.

Cardio and vascular …

Read more
  • 0

Integer completes $220M Oscor acquisition

Integer Holdings (NYSE: ITGR) announced today that it has completed its purchase of Oscor — a deal that expands the capabilities of what was already one of the world’s largest medtech contract manufacturers.

Integer said the acquisition would cost $220 million when it first announced its plans in October.

Get the full story on our sister site Medical Design & Outsourcing. 

Read more
  • 0

Integer completes $220M Oscor acquisition

Integer Holdings (NYSE: ITGR) announced today that it has completed its purchase of Oscor — a deal that expands the capabilities of what was already one of the world’s largest medtech contract manufacturers.

Integer said the acquisition would cost $220 million when it first announced its plans in October.

Oscor is the creator and marketer of various specialized implantable cardiac pacing and neurostimulation leads, venous access systems and diagnostic catheters. Integer officials note that Oscor’s finished introducer systems, guiding sheaths and proprietary lead wire technologies give it even more exposure to higher-growth markets — including cardiac pacing, electrophysiology, neurostimulation, cardiovascular, peripheral vascular and structural heart.

Integer’s Oscor acquisition adds design, development and manufacturing operations in Palm Harbor, Florida and the Dominican Republic, business offices in Germany and 900 employees.

Read more
  • 0

Integer beats The Street in Q3, plans to acquire Oscor

Integer Holdings (NYSE:ITGR) posted third-quarter results today that beat the consensus forecast on Wall Street — and announced plans to spend $220 million to acquire Oscor.

The Plano, Texas–based medtech contract manufacturing giant plans to finance the acquisition with debt. Integer officials expect the deal to close in December under customary closing conditions. They see the acquisition broadening Integer’s product portfolio, expanding its R&D capabilities, and adding low-cost manufacturing capacity.

Get the full story on our sister site Medical Design & Outsourcing. 

Read more
  • 0

Integer beats The Street in Q3, plans to acquire Oscor

Integer Holdings (NYSE:ITGR) posted third-quarter results today that beat the consensus forecast on Wall Street — and announced plans to spend $220 million to acquire Oscor.

The Plano, Texas–based medtech contract manufacturing giant plans to finance the acquisition with debt. Integer officials expect the deal to close in December under customary closing conditions. They see the acquisition broadening Integer’s product portfolio, expanding its R&D capabilities, and adding low-cost manufacturing capacity.

“We’re excited to welcome Oscor’s approximately 900 associates to Integer, who will bring a trusted brand with 40 years of medical device development and manufacturing combined with a complementary product offering and extensive intellectual property portfolio,” Integer CEO Joseph Dziedzic said in a news release.

Dziedzic suggested that Integer is in a financial position to continue shopping: “The execution of our …

Read more
  • 0